News

Pataigin Appoints Deborah Elvins as Strategic Advisor

SEATTLE, WA – 30 March, 2022 – Microbiology diagnostics company Pataigin today appointed Deborah A. Elvins as an advisor to the company on business strategy and other business …

Direct-From-Specimen Results to be Presented at ECCMID 2022 Conference

LISBON, Portugal: Results will be presented from a study of Pataigin’s rapid bacterial ID assay, direct from clinical specimens.

At the 32nd European Congress of Clinical Microbiology & …

Pataigin Introduces First Multiplex Lipid Microbiology Kit

VIENNA, Austria, BALTIMORE Maryland, and Seattle, Washington – 13 July 2021: At the 31st European Congress of Clinical Microbiology & Infectious Diseases (ECCMID, www.eccmid.org), Pataigin …

Pataigin Awarded NIH Grant to Improve Antimicrobial Stewardship

Today, the US NIH awarded Pataigin a research grant to further development of Pataigin’s Rigel antimicrobial susceptibility test.

“We thank the NIH for supporting this research,” …